首页 | 本学科首页   官方微博 | 高级检索  
     

补救性应用替罗非班治疗急性心肌梗死的临床观察
引用本文:陈震,周俊高,徐曙东,孙欣. 补救性应用替罗非班治疗急性心肌梗死的临床观察[J]. 现代医学, 2010, 38(2): 141-143. DOI: 10.3969/j.issn.1671-7562.2010.02.012
作者姓名:陈震  周俊高  徐曙东  孙欣
作者单位:扬州大学附属泰兴医院,心内科,江苏,泰兴,225400
摘    要:
目的:观察补救性应用替罗非班治疗急性心肌梗死的效果及安全性.方法:选择42例常规治疗失败的急性心肌梗死患者,分为治疗组(19例)及对照组(23例).对照组接受常规药物治疗;治疗组除接受常规药物治疗外,接受替罗非班治疗.结果:治疗组胸痛缓解时间显著缩短,梗死后心绞痛、严重并发症发生率均低于对照组(P<0.05);死亡率、血清超敏C反应蛋白(hs-CRP)水平虽有降低趋势,但无显著差异,出血并发症无显著差异.结论:补救性运用替罗非班可有效缓解症状,且治疗安全有效,值得进一步研究.

关 键 词:替罗非班  急性心肌梗死  补救

Remedial use of tirofiban in patients with acute myocardial infarction
CHEN Zhen,ZHOU Jun-gao,XU Shu-dong,SUN Xin. Remedial use of tirofiban in patients with acute myocardial infarction[J]. Modern Medical JOurnal, 2010, 38(2): 141-143. DOI: 10.3969/j.issn.1671-7562.2010.02.012
Authors:CHEN Zhen  ZHOU Jun-gao  XU Shu-dong  SUN Xin
Affiliation:CHEN Zhen,ZHOU Jun-gao,XU Shu-dong,SUN Xin(Department of Cardiology,Taixing Hospital Affiliated to Yangzhou University,Taixing 225400,China)
Abstract:
Objective:To study the efficacy and safety of the remedial use of tirofiban in patients with acute myocardial infarction(AMI).Methods:42 patients who failed in conventional therapy were divided into the tirofiban group(n=19) and the control group(n=23).The time of chest pain relieving and the number of patients repeatedly suffered from angina were compared.The complications and mortality of AMI and blooding were observed.Serum hs-CRP levels were determined by the latex enhanced immunoturbidimetric method on...
Keywords:tirofiban  acute myocardial infarction  rescue  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号